Unified trial platform RedCap Cloud offers a single platform that combines EDC, Randomization, ePRO and eConsent to support IIT/IIS, RCT and RWE studies, presenting a cross-functional opportunity to upsell integrated data management and analytics capabilities.

Global research focus Target markets include MedTech, Academic/IIS/IIT, Biotech, Health Systems, Registries and RWE projects, suggesting sales opportunities across large, globally distributed trial programs and institutions seeking end-to-end data solutions.

Recent product expansion Launch of REDCap Cloud 2.0 indicates a growing emphasis on unifying real-world evidence with trial data, creating a potential to pitch enhanced analytics, interoperability features, and scalable deployment for complex studies.

Growth signals Revenue is in the mid to high multi-million range with a mid-size employee base, aligning with mid-market to lower-enterprise buyers who may seek mid-tier implementational services, support packages, and training offerings.

Tech and engagement Utilizes a broad tech stack (AWS, Amplitude, Hotjar, Twilio, PayPal, etc.) and digital engagement tools, presenting opportunities to propose optimized cloud hosting, data security enhancements, and seamless customer communications as part of a procurement package.